Home Newsfeeds Check-Cap Q2 EPS $(0.04) Beats $(0.05) Estimate

Check-Cap Q2 EPS $(0.04) Beats $(0.05) Estimate

Check-Cap (NASDAQ:CHEK) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 63.64 percent increase over losses of $(0.11) per share from the same

byBill Haddad

August 31, 2022

1 minute read

Event Contract Trading Signals Uncertainty In Apple Monopoly Case During WWDC

By Michael Juliano

June 11, 5:58 PM

Apple's chance of being seen as monopoly fluctuated during WWDC, with event contract trader Kalshi reporting a high of 68% on April 11.

AAPL

Nasdaq Down 1%; Capital One Set To Buy Discover

By Avi Kapoor

February 20, 10:54 AM

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell 1% to 15,617.93. The S&P 500 also fell, dropping, 0.55% to 4,977.99.

AGRI

Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine

By Vandana Singh

September 14, 9:14 AM

Pfizer Inc (NYSE:PFE) has dosed the first participants in the Phase 3 trial of its quadrivalent modified RNA (modRNA) influenza vaccine…

BNTX

Select Energy Services Q3 EPS $0.22 Beats $0.16 Estimate, Sales $375.07M Beat $355.99M Estimate

By Benzinga Newsdesk

November 2, 5:55 PM

Select Energy Services (NYSE:WTTR) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.16 by 37.5 percent. This is a 257.14 percent increase over losses of $(0.14) per share

WTTR

Check-Cap Q2 EPS $(0.04) Beats $(0.05) Estimate

Related Posts

Event Contract Trading Signals Uncertainty In Apple Monopoly Case During WWDC

Nasdaq Down 1%; Capital One Set To Buy Discover

Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine

Select Energy Services Q3 EPS $0.22 Beats $0.16 Estimate, Sales $375.07M Beat $355.99M Estimate